Xcout Intel
Kanvas Biosciences
Kanvas Biosciences, Inc. is a for-profit research and development company founded in 2020 and based in New Jersey that operates in the healthcare and biotechnology sectors.
Subscribe to see Kanvas Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kanvas Biosciences at a glance
Kanvas Biosciences is a drug discovery company headquartered in United States. It has raised at least $15.7M across the 2 funding rounds on record. Its most recent funding round raised $3.9M in March 2024. Xcout tracks 8 named people at Kanvas Biosciences, including Lee Swem (Chief Development Officer).
Kanvas Biosciences leadership
- Lee SwemChief Development Officer
- Phil BurnhamChief Scientific Officer
- Matthew P. ChengCo-founder and Chief Executive Officer
- Hao ShiCo-founder and Chief Technical Officer
- Aditya BhallaVP Process Development and Manufacturing
- Kyle JacobyVP Clinical Research
2 more named people on record for Kanvas Biosciences, with roles, board committees and tenure — see the full roster →
Kanvas Biosciences funding rounds
At least $15.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3.9M | — | |
| SEC Form D filing | $11.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Kanvas Biosciences competitors
A few of Kanvas Biosciences's closest competitors — see the full list of competitors and alternatives →
Ahammune Biosciences is an India-based drug-discovery biotechnology company focused on developing small-molecule therapies for immune-mediated and inflammatory diseases. It serves pharmaceutical and healthcare markets by advancing novel immunomodulatory drug candidates toward clinical development.
Cidara Therapeutics, Inc. is a biotechnology company focused on developing late-phase antiviral and immunotherapy agents, with operations based in San Diego, California and Rahway, New Jersey.
Kadmus Pharmaceuticals is a pharmaceutical company headquartered in Irvine, California. The enterprise focuses on drug discovery and development within the life sciences sector.
Altay Therapeutics, Inc. is a biotechnology company founded in 2019 and headquartered in the San Francisco Bay Area, California. The company focuses on developing therapeutics within the biotechnology sector.
Createrna, Inc. is an innovative biopharmaceutical company dedicated to the discovery and development of treatments for immunology, respiratory, and cardiovascular diseases. The company focuses its research pipeline on addressing complex chronic conditions through targeted therapeutic approaches. Their portfolio highlights early-stage pharmaceutical developments in specialized medical fields.
Mikrobiomik is a pioneering biopharmaceutical company headquartered in Bilbao, Spain, specializing in the research and development of therapies based on the human gut microbiota. Founded in 2018, the company operates out of the BIC Bizkaia intelligent building to restore health through microbiome-based treatments.
Get Kanvas Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kanvas Biosciences in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access